Welsh N. Are off-target effects of imatinib the key to improving beta-cell function in diabetes?. ujms [Internet]. 2022 Sept. 14 [cited 2026 Nov. 13];127(1). Available from: https://ujms.net/index.php/ujms/article/view/8841